259 related articles for article (PubMed ID: 10815898)
1. Microsatellite instability and expression of hMLH-1 and hMSH-2 in sebaceous gland carcinomas as markers for Muir-Torre syndrome.
Entius MM; Keller JJ; Drillenburg P; Kuypers KC; Giardiello FM; Offerhaus GJ
Clin Cancer Res; 2000 May; 6(5):1784-9. PubMed ID: 10815898
[TBL] [Abstract][Full Text] [Related]
2. Loss of mismatch repair proteins in sebaceous gland tumors.
Popnikolov NK; Gatalica Z; Colome-Grimmer MI; Sánchez RL
J Cutan Pathol; 2003 Mar; 30(3):178-84. PubMed ID: 12641777
[TBL] [Abstract][Full Text] [Related]
3. Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations: establishment of immunohistochemical analysis as a screening test.
Mathiak M; Rütten A; Mangold E; Fischer HP; Ruzicka T; Friedl W; Propping P; Kruse R
Am J Surg Pathol; 2002 Mar; 26(3):338-43. PubMed ID: 11859205
[TBL] [Abstract][Full Text] [Related]
4. Mismatch repair proteins expression and microsatellite instability in skin lesions with sebaceous differentiation: a study in different clinical subgroups with and without extracutaneous cancer.
Cesinaro AM; Ubiali A; Sighinolfi P; Trentini GP; Gentili F; Facchetti F
Am J Dermatopathol; 2007 Aug; 29(4):351-8. PubMed ID: 17667167
[TBL] [Abstract][Full Text] [Related]
5. Microsatellite instability and immunostaining for MSH-2 and MLH-1 in cutaneous and internal tumors from patients with the Muir-Torre syndrome.
Machin P; Catasus L; Pons C; Muñoz J; Conde-Zurita JM; Balmaña J; Barnadas M; Martí RM; Prat J; Matias-Guiu X
J Cutan Pathol; 2002 Aug; 29(7):415-20. PubMed ID: 12139636
[TBL] [Abstract][Full Text] [Related]
6. BRAF/KRAS gene sequencing of sebaceous neoplasms after mismatch repair protein analysis.
Cornejo KM; Hutchinson L; Deng A; Tomaszewicz K; Welch M; Lyle S; Dresser K; Cosar EF
Hum Pathol; 2014 Jun; 45(6):1213-20. PubMed ID: 24767862
[TBL] [Abstract][Full Text] [Related]
7. Microsatellite instability and mismatch-repair protein expression in hereditary and sporadic colorectal carcinogenesis.
Pedroni M; Sala E; Scarselli A; Borghi F; Menigatti M; Benatti P; Percesepe A; Rossi G; Foroni M; Losi L; Di Gregorio C; De Pol A; Nascimbeni R; Di Betta E; Salerni B; de Leon MP; Roncucci L
Cancer Res; 2001 Feb; 61(3):896-9. PubMed ID: 11221877
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical pattern of MLH1/MSH2 expression is related to clinical and pathological features in colorectal adenocarcinomas with microsatellite instability.
Lanza G; Gafà R; Maestri I; Santini A; Matteuzzi M; Cavazzini L
Mod Pathol; 2002 Jul; 15(7):741-9. PubMed ID: 12118112
[TBL] [Abstract][Full Text] [Related]
9. Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or keratoacanthomas.
Ponti G; Losi L; Pedroni M; Lucci-Cordisco E; Di Gregorio C; Pellacani G; Seidenari S
J Invest Dermatol; 2006 Oct; 126(10):2302-7. PubMed ID: 16826164
[TBL] [Abstract][Full Text] [Related]
10. [Mismatch pair defective phenotype in hereditary nonpolyposis colorectal cancer in the Chinese].
Cai Q; Sun MH; Lu HF; Xu XL; Min DL; Zhang TM; Shi DR
Zhonghua Zhong Liu Za Zhi; 2003 Sep; 25(5):420-4. PubMed ID: 14575560
[TBL] [Abstract][Full Text] [Related]
11. MSH-2 and MLH-1 protein expression in Muir Torre syndrome-related and sporadic sebaceous neoplasms.
Morales-Burgos A; Sánchez JL; Figueroa LD; De Jesús-Monge WE; Cruz-Correa MR; González-Keelan C; Nazario CM
P R Health Sci J; 2008 Dec; 27(4):322-7. PubMed ID: 19069357
[TBL] [Abstract][Full Text] [Related]
12. Sporadic colorectal adenocarcinomas with high-frequency microsatellite instability.
Gafà R; Maestri I; Matteuzzi M; Santini A; Ferretti S; Cavazzini L; Lanza G
Cancer; 2000 Nov; 89(10):2025-37. PubMed ID: 11066042
[TBL] [Abstract][Full Text] [Related]
13. Cystic sebaceous tumors as marker lesions for the Muir-Torre syndrome: a histopathologic and molecular genetic study.
Rütten A; Burgdorf W; Hügel H; Kutzner H; Hosseiny-Malayeri HR; Friedl W; Propping P; Kruse R
Am J Dermatopathol; 1999 Oct; 21(5):405-13. PubMed ID: 10535567
[TBL] [Abstract][Full Text] [Related]
14. Different genetic pathways in the development of periocular sebaceous gland carcinomas in presumptive Muir-Torre syndrome patients.
Goldberg M; Rummelt C; Foja S; Holbach LM; Ballhausen WG
Hum Mutat; 2006 Feb; 27(2):155-62. PubMed ID: 16395674
[TBL] [Abstract][Full Text] [Related]
15. DNA mismatch repair defects and microsatellite instability status in periocular sebaceous carcinoma.
Rajan Kd A; Burris C; Iliff N; Grant M; Eshleman JR; Eberhart CG
Am J Ophthalmol; 2014 Mar; 157(3):640-7.e1-2. PubMed ID: 24321472
[TBL] [Abstract][Full Text] [Related]
16. Frequency of microsatellite instability in unselected sebaceous gland neoplasias and hyperplasias.
Kruse R; Rütten A; Schweiger N; Jakob E; Mathiak M; Propping P; Mangold E; Bisceglia M; Ruzicka T
J Invest Dermatol; 2003 May; 120(5):858-64. PubMed ID: 12713593
[TBL] [Abstract][Full Text] [Related]
17. Fordyce granules and hyperplastic mucosal sebaceous glands as distinctive stigmata in Muir-Torre syndrome patients: characterization with reflectance confocal microscopy.
Ponti G; Meschieri A; Pollio A; Ruini C; Manfredini M; Longo C; Mandel VD; Ciardo S; Tomasi A; Giannetti L; Pellacani G
J Oral Pathol Med; 2015 Aug; 44(7):552-7. PubMed ID: 25213213
[TBL] [Abstract][Full Text] [Related]
18. Microsatellite instability and expression of MLH1 and MSH2 in carcinomas of the small intestine.
Planck M; Ericson K; Piotrowska Z; Halvarsson B; Rambech E; Nilbert M
Cancer; 2003 Mar; 97(6):1551-7. PubMed ID: 12627520
[TBL] [Abstract][Full Text] [Related]
19. Frequent microsatellite instability in sporadic tumors of the upper urinary tract.
Hartmann A; Zanardo L; Bocker-Edmonston T; Blaszyk H; Dietmaier W; Stoehr R; Cheville JC; Junker K; Wieland W; Knuechel R; Rueschoff J; Hofstaedter F; Fishel R
Cancer Res; 2002 Dec; 62(23):6796-802. PubMed ID: 12460887
[TBL] [Abstract][Full Text] [Related]
20. Defective DNA mismatch repair activity is common in sebaceous neoplasms, and may be an ineffective approach to screen for Lynch syndrome.
Lamba AR; Moore AY; Moore T; Rhees J; Arnold MA; Boland CR
Fam Cancer; 2015 Jun; 14(2):259-64. PubMed ID: 25637498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]